Seattle biotech firm Shape Therapeutics inks gene therapy deal
4.9 (86) · $ 10.00 · In stock
Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer’s
Shape Therapeutics Inc.
Biomolecules, Free Full-Text
Health/Life Sciences – Page 14 of 52 - GeekWire
Shape Therapeutics Inc.
Suicide gene therapy in cancer and HIV-1 infection: An alternative
Collin H. posted on LinkedIn
Fierce Biotech's 2022 Fierce 15
Health/Life Sciences – Page 14 of 52 - GeekWire
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells
NextGen Class of 2024: Top Life Sciences Startups to Watch This
Health/Life Sciences – Page 14 of 52 - GeekWire
White House cybersecurity summit to include 's Andy Jassy, Microsoft's Satya Nadella – GeekWire
Shape Therapeutics Inc.
Otsuka, Shape Ink Potential $1.5B Deal to Develop Eye AAV Gene
